摘要:
Pharmaceutical compositions which have steroid C17,20 lyase inhibiting activity and are useful as preventive or therapeutic agents for prostatism or tumors such as breast cancer, more particularly, steroid C17,20 lyase inhibitors characterized by containing a compound of the general formula (I) or a salt or prodrug thereof, wherein A1 is an optionally substituted aromatic hydrocarbon group or an optionally substituted heterocyclic group; and one of A2 or A3 is hydrogen, halogeno, an optionally substituted C¿1-4? aliphatic hydrocarbon group, or optionally esterified carboxyl, and the other is an optionally substituted heterocyclic group, with the proviso that at least one of A?1, A2, and A3¿ is optionally substituted 3-pyridyl.
摘要:
Provided are compounds which have steroid C17,20 lyase inhibiting effect and are useful as preventive or therapeutic agents for prostatism and tumors including breast cancer. Specifically, compounds represented by the general formula (Ia) or (Ib), or salts thereof: (Ia) (Ib) wherein R is hydrogen or a protecting group; R1 is lower alkyl or cycloalkyl; and A and B are each an optionally substituted 5- or 6-membered ring bearing an amide linkage in the ring.
摘要:
The present invention provides a compound represented by formula (I), wherein R is a hydrogen atom or a protecting group, R1 is a lower alkyl group or a cyclic alkyl group, R2 is a group represented by formula (1), (wherein a ring A1 is a 5- or 6-membered ring containing an oxygen atom optionally having substituents, and a ring A2 and a ring A3 may have substituents), a group represented by formula (2), (wherein the ring B1 is a 5- or 6-membered ring containing an oxygen atom optionally having substituents and a ring B2 and a ring B3 may have substituents) or a group of formula (3), (wherein each of R?3 and R5¿ is a hydrogen atom, a lower alkyl group optionally having substituents, a hydroxyl group optionally having substituents, a thiol group optionally having substituents, an amino group optionally having substituents, an acyl group or a halogen atom, R4 is an aromatic hydrocarbon group optionally having substituents, a heterocyclic group optionally having substituents or a carbamoyl group optionally having substituents, R6 is an optionally halogenated lower alkyl group and n is an integer of 0 to 3), or a salt thereof, which has an inhibitory activity of steroid C¿17-20?-lyase and are useful for preventing and treating a mammal suffering from, for example, primary tumor, its metastasis and recurrence thereof, and various symptoms accompanied with these cancer, various diseases such as prostatic hypertrophy, virilism, hirsutism, male pattern alopecia, precocious puberty, endometriosis, uterus myoma, mastopathy, polycystic ovary syndrome, etc.
摘要:
The present invention provides a compound having a steroid C17,20-lyase-inhibitory activity and useful for the therapy and prophylaxis of tumor such as prostatism, breast cancer and the like, and a method for efficiently separating an optically active compound of this compound from a mixture of optical isomers thereof, a compound of the formula:wherein each symbol is as defined in the specification, a salt thereof or a prodrug thereof, and a method for obtaining an optically active compound by optically resolving a mixture of optical isomers by the use of a resolving agent such as tartranilic acid and the like.